Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer

PURPOSE: Prostate cancer (PCa) is one of the most common cancers and one of the leading causes of death worldwide. Thus, one major issue in PCa research is to accurately distinguish between indolent and clinically significant (csPCa) to reduce overdiagnosis and overtreatment. In this study, we aim t...

Descripción completa

Detalles Bibliográficos
Autores principales: Frantzi, Maria, Heidegger, Isabel, Roesch, Marie C., Gomez-Gomez, Enrique, Steiner, Eberhard, Vlahou, Antonia, Mullen, William, Guler, Ipek, Merseburger, Axel S., Mischak, Harald, Culig, Zoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427869/
https://www.ncbi.nlm.nih.gov/pubmed/35841414
http://dx.doi.org/10.1007/s00345-022-04077-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427869/
https://www.ncbi.nlm.nih.gov/pubmed/35841414
http://dx.doi.org/10.1007/s00345-022-04077-1

Ejemplares similares